Firm Events
District Court vs. PTAB: Strategic Forum Selection in Life Sciences Patent Disputes
December 10, 2026 | 12:00 PM – 1:00 PM ET
On December 23, 2024, the United States 5th Circuit Court of Appeals granted the government’s motion for a “stay pending appeal”[1] of the Texas Top Cop Shop, Inc. v. Garland preliminary injunction prohibiting enforcement by FinCEN of the CTA.[2] The Court of Appeals found, among other things, that the CTA “was within [Congress’] commerce power”.[3]
The Court of Appeals decision and order effectively reinstated the beneficial ownership information reporting (BOI) deadlines under the CTA and its regulations, including the January 1, 2025 deadline for filings by non-exempt reporting companies existing prior to January 1, 2024. The 5th Circuit ordered that the appeal be expedited “to the next available oral argument panel.”
Shortly after the 5th Circuits’ decision and order, FinCEN issued an Alert[4] discussing the 5th Circuit’s decision and order and announcing the extension of the January 1, 2025 deadline for filing certain initial CTA Beneficial Ownership Reports to January 13, 2025.
The Alert included a number of other extensions and important deadlines for CTA BOI reporting, including a reminder that as of January 1, 2025, all newly formed entities that are not exempt under the CTA and existing Regulations only have 30 days from the date of formation to make their initial BOI Reports.
—-
[1] Texas Top Cop Shop, Inc. v. Merrick Garland, U.S. Attorney General, et al . 5thCir. No. 24-40792
[2] Texas Top Cop Shop, Inc. v. Merrick Garland, U.S. Attorney General, et al . USDC ED TX, No. 4:24-CV-478.
[3] Texas Top Cop Shop, Inc. v. Merrick Garland, U.S. Attorney General, et al . 5thCir. No. 24-40792., at pg. 4.
Insight Industries + Practices
This just in
Speaking Engagements
Performance on Trial: The Construction Manager’s Standard of Care Examined from All Angles
December 2, 2026 | 4:15 PM – 5:30 PM ET
The Hyatt Regency Huntington Beach
Huntington Beach, CA
Speaking Engagements
ACI’s 31st Annual Conference on Drug & Medical Device Litigation – 2026
December 2 – 3, 2026
New York Marriott Marquis
1535 Broadway, New York, NY 10036
Speaking Engagements
Fundamentals of Investment Adviser Regulation 2026
November 19, 2026 | 2:30 PM – 3:30 PM ET
PLI New York
1177 Avenue of the Americas, Entrance on 45th Street, New York, NY 10036